Fernando Aguila-Jaen

Granada, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Regression of Left Ventricular Hypertrophy in Primary Aldosteronism.

Regression of Left Ventricular Hypertrophy in Primary Aldosteronism.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: August 17, 2026

Influence of body mass index on disease severity and treatment outcomes in primary aldosteronism.

Influence of body mass index on disease severity and treatment outcomes in primary aldosteronism.

Journal: Journal of the Endocrine Society

Published: April 28, 2026

Resistant hypertension and epileptic seizures: a possible modulatory role of renal denervation-a case report.

Resistant hypertension and epileptic seizures: a possible modulatory role of renal denervation-a case report.

Journal: European heart journal. Case reports

Published: November 18, 2025

Predictors of treatment response to mineralocorticoid receptor antagonists in primary aldosteronism: insights from the SPAIN-ALDO registry.

Predictors of treatment response to mineralocorticoid receptor antagonists in primary aldosteronism: insights from the SPAIN-ALDO registry.

Journal: Journal of hypertension

Published: August 21, 2025

Mineralocorticoid Receptor Antagonist Pre-Adrenalectomy in Primary Aldosteronism.

Mineralocorticoid Receptor Antagonist Pre-Adrenalectomy in Primary Aldosteronism.

Journal: The Journal of clinical endocrinology and metabolism

Published: July 18, 2025

Impact of primary aldosteronism on calcium phosphate homeostasis. Results from the SPAIN-ALDO.

Impact of primary aldosteronism on calcium phosphate homeostasis. Results from the SPAIN-ALDO.

Journal: Journal of endocrinological investigation

Published: November 04, 2024

Real-world efficacy and safety of baroreceptor activation therapy in a series of patients with refractory arterial hypertension.

Real-world efficacy and safety of baroreceptor activation therapy in a series of patients with refractory arterial hypertension.

Journal: Hipertension y riesgo vascular

Published: October 07, 2024

Impact of primary aldosteronism on kidney function: results from the SPAIN-ALDO registry.

Impact of primary aldosteronism on kidney function: results from the SPAIN-ALDO registry.

Journal: Journal of hypertension

Published: July 25, 2024

Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney.

Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney.

Journal: Blood pressure

Published: June 24, 2024

Position paper on retinal arterial occlusion. SEMI-SERV.

Position paper on retinal arterial occlusion. SEMI-SERV.

Journal: Revista clinica espanola

Published: June 19, 2024

Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Spain.

Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Spain.

Journal: REC, interventional cardiology

Published: April 12, 2024

Influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism: a cohort study.

Influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism: a cohort study.

Journal: European journal of endocrinology

Published: January 13, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026